Start > Forskning > Janus serumbank > Forskning > Publikasjoner

Oppdatert 7. mai 2012

  1. Hilde Langseth, Randi Gislefoss, Jan Ivar Martinsen and Steinar Tretli
    Scientific scope of integrating research activities in the Janus Serum Bank and Cancer Registry of Norway
    Norsk Epidemiologi 2012; 21 (2): 185-190 185
    http://www.ntnu.no/ojs/index.php/norepid/article/view/1492/1337
  2. Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J.
    Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer.
    Am J Epidemiol. 2012 Mar 14.
    http://www.ncbi.nlm.nih.gov/pubmed/22419740
  3. Hustad S, Eussen S, Midttun O, Ulvik A, van de Kant PM, Morkrid L, Gislefoss R, Ueland PM. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 2012; 58(2):402-410.
    http://www.ncbi.nlm.nih.gov/pubmed/22194632?dopt=Citation
  4. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012; 23(2):363-370.
    http://www.ncbi.nlm.nih.gov/pubmed/22193397?dopt=Citation
  5. Dahlstrom LA, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L, Wiklund F, Skare GB, Eklund C, Sjolin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J. Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer. Cancer Epidemiol Biomarkers Prev 2011; 20(12):2541-2550.
    http://www.ncbi.nlm.nih.gov/pubmed/21994401?dopt=Citation
  6. Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011; 8(3):506-516.
    http://www.ncbi.nlm.nih.gov/pubmed/21558792?dopt=Citation
  7. Leon ME, Beane Freeman LE, Douwes J, Hoppin JA, Kromhout H, Lebailly P, Nordby KC, Schenker M, Schuz J, Waring SC, Alavanja MC, Annesi-Maesano I, Baldi I, Dalvie MA, Ferro G, Fervers B, Langseth H, London L, Lynch CF, McLaughlin J, Merchant JA, Pahwa P, Sigsgaard T, Stayner L, Wesseling C, Yoo KY, Zahm SH, Straif K, Blair A. AGRICOH: a consortium of agricultural cohorts. Int J Environ Res Public Health 2011; 8(5):1341-1357.
    http://www.ncbi.nlm.nih.gov/pubmed/21655123?dopt=Citation
  8. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 2010; 102(11):1665-1669.
    http://www.ncbi.nlm.nih.gov/pubmed/20407437?dopt=Citation
  9. Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Morkrid L, Ueland PM. Analytical recovery of folate and its degradation products in human serum stored at -25 degrees C for up to 29 years. J Nutr 2010; 140(3):522-526.
    http://www.ncbi.nlm.nih.gov/pubmed/20071651?dopt=Citation
  10. Langseth H, Luostarinen T, Bray F, Dillner J. Ensuring quality in studies linking cancer registries and biobanks. Acta Oncol 2010; 49(3):368-377.
    http://www.ncbi.nlm.nih.gov/pubmed/20059313?dopt=Citation
  11. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009; 47(5):596-603.
    http://www.ncbi.nlm.nih.gov/pubmed/19290843?dopt=Citation
  12. Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Love A, Mahlamaki E, Thoresen S, Tryggvadottir L, Wadell G, Youngman L, Lehtinen M. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 2009; 169(4):480-488.
    http://www.ncbi.nlm.nih.gov/pubmed/19074773?dopt=Citation
  13. Langseth H, Gislefoss R, Martinsen JI, Stornes A, Lauritzen M, Andersen A, Jellum E, Dillner J. The Janus Serum Bank: From sample collection to cancer research. Cancer in Norway 2009.
    http://www.kreftregisteret.no/Global/29-01-2010%20CIN_ 2008_Special_Issue_Janus_Web.pdf
  14. Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, Blair A, Rothman N, McGlynn KA. Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environ Health Perspect 2009; 117(10):1514-1519.
    http://www.ncbi.nlm.nih.gov/pubmed/20019899?dopt=Citation
  15. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009; 100(3):450-454.
    http://www.ncbi.nlm.nih.gov/pubmed/19156140?dopt=Citation
  16. Gislefoss RE, Grimsrud TK, Morkrid L. Long-term stability of serum components in the Janus Serum Bank. Scand J Clin Lab Invest 2008; 68(5):402-409.
    http://www.ncbi.nlm.nih.gov/pubmed/18752145?dopt=Citation
  17. Jorgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008; 67(6):860-866.
    http://www.ncbi.nlm.nih.gov/pubmed/17644543?dopt=Citation
  18. Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100(3):170-183.
    http://www.ncbi.nlm.nih.gov/pubmed/18230794?dopt=Citation
  19. Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study. Lung Cancer 2008; 61(2):235-243.
    http://www.ncbi.nlm.nih.gov/pubmed/18281122?dopt=Citation
  20. Vatten LJ, Holly JM, Gunnell D, Tretli S. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Cancer Epidemiol Biomarkers Prev 2008; 17(8):2097-2100.
    http://www.ncbi.nlm.nih.gov/pubmed/18708402?dopt=Citation
  21. Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Res 2007; 67(11):5545-5552.
    http://www.ncbi.nlm.nih.gov/pubmed/17545638?dopt=Citation
  22. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007; 56(7):918-925.
    http://www.ncbi.nlm.nih.gov/pubmed/17317788?dopt=Citation
  23. Kjaerheim K, Roe OD, Waterboer T, Sehr P, Rizk R, Dai HY, Sandeck H, Larsson E, Andersen A, Boffetta P, Pawlita M. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 2007; 120(11):2459-2465.
    http://www.ncbi.nlm.nih.gov/pubmed/17315193?dopt=Citation
  24. Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J. No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus. Int J Cancer 2007; 121(5):1098-1102.
    http://www.ncbi.nlm.nih.gov/pubmed/17471560?dopt=Citation
  25. Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyronen PP, Lenner P, Luostarinen T, Love A, Ogmundsdottir H, Stattin P, Tenkanen L, Tryggvadottir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 2007; 46(3):286-307.
    http://www.ncbi.nlm.nih.gov/pubmed/17450464?dopt=Citation
  26. Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(6):1184-1188.
    http://www.ncbi.nlm.nih.gov/pubmed/16775179?dopt=Citation
  27. Gislefoss R, Jellum E. The Janus serum bank and biomarkers of cancer. Norsk Epidemiologi 2006; 16(1):53-57.
    http://www.ntnu.no/ojs/index.php/norepid/article/view/206
  28. Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M. Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2005; 14(2):385-389.
    http://www.ncbi.nlm.nih.gov/pubmed/15734962?dopt=Citation
  29. Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14(12):2952-2955.
    http://www.ncbi.nlm.nih.gov/pubmed/16365015?dopt=Citation
  30. Tedeschi R, Luostarinen T, De PP, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J. Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk. Br J Cancer 2005; 93(7):834-837.
    http://www.ncbi.nlm.nih.gov/pubmed/16136049?dopt=Citation
  31. Bjorge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Trope CG, Dorum A. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. Br J Cancer 2004; 91(10):1829-1834.
    http://www.ncbi.nlm.nih.gov/pubmed/15477862?dopt=Citation
  32. Chiba H, Tretli S, Lund E, Wakai K, Takezaki T, Senoo H, Sonoda S, Tajima K. Lack of HTLV-I carriers in the Sami, an ethnic group living in the Arctic area in Norway. Asian Pac J Cancer Prev 2004; 5(1):50-53.
  33. Ekstrom PO, Bjorge T, Dorum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E. Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis. Anal Chem 2004; 76(15):4406-4409.
    http://www.ncbi.nlm.nih.gov/pubmed/15283579?dopt=Citation
  34. Luostarinen T, Lehtinen M, Bjorge T, Abeler V, Hakama M, Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen T. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur J Cancer 2004; 40(7):1058-1065.
    http://www.ncbi.nlm.nih.gov/pubmed/15093583?dopt=Citation
  35. Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004; 108(3):418-424.
    http://www.ncbi.nlm.nih.gov/pubmed/14648709?dopt=Citation
  36. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109(1):149-152.
    http://www.ncbi.nlm.nih.gov/pubmed/14735482?dopt=Citation
  37. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108(1):104-108.
    http://www.ncbi.nlm.nih.gov/pubmed/14618623?dopt=Citation
  38. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13(12):2175-2180.
    http://www.ncbi.nlm.nih.gov/pubmed/15598777?dopt=Citation
  39. Jellum E, Gislefoss RE. Serumbanken "Janus" i kreftforskning: Fra håndverk til høy teknologi. Klinisk kjemi (Rikshospitalet) 2003;403-15.
  40. Lehtinen M, Pawlita M, Zumbach K, Lie K, Hakama M, Jellum E, Koskela P, Luostarinen T, Paavonen J, Pukkala E, Sigstad E, Thoresen S, Dillner J. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol 2003; 188(1):49-55.
    http://www.ncbi.nlm.nih.gov/pubmed/12548195?dopt=Citation
  41. Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen S, Lam H, Shen C, Brunham RC. Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol 2003; 189(5):1287-1292.
    http://www.ncbi.nlm.nih.gov/pubmed/14634555?dopt=Citation
  42. Stattin P, Kaaks R, Johansson R, Gislefoss R, Soderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T. Plasma leptin is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12(5):474-475.
    http://www.ncbi.nlm.nih.gov/pubmed/12750247?dopt=Citation
  43. Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SO, Dillner J. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87(1):61-64.
    http://www.ncbi.nlm.nih.gov/pubmed/12085257?dopt=Citation
  44. Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries. Am J Epidemiol 2002; 156(8):687-692.
    http://www.ncbi.nlm.nih.gov/pubmed/12370156?dopt=Citation
  45. Mork J, Lie AK, Glattre E, Clark S, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Wang Z, Youngman L, Lehtinen M, Dillner J. Humant papillomavirus-infeksjon som risikofaktor for plateepitel-karsinom. Tidsskr Nor Laegeforen 2002; 122(16):1544-8.
    http://tidsskriftet.no/article/560600
  46. Sigstad E, Lie AK, Luostarinen T, Dillner J, Jellum E, Lehtinen M, Thoresen S, Abeler V. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. Br J Cancer 2002; 87(2):175-180.
    http://www.ncbi.nlm.nih.gov/pubmed/12107839?dopt=Citation
  47. Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 2002; 99(1):124-129.
    http://www.ncbi.nlm.nih.gov/pubmed/11948503?dopt=Citation
  48. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S, Youngman L, Paavonen J. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001; 285(1):47-51.
    http://www.ncbi.nlm.nih.gov/pubmed/11150108?dopt=Citation
  49. Hostmark AT, Glattre E, Jellum E. Effect of long-term storage on the concentration of albumin and free fatty acids in human sera. Scand J Clin Lab Invest 2001; 61(6):443-447.
    http://www.ncbi.nlm.nih.gov/pubmed/11681533?dopt=Citation
  50. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344(15):1125-1131.
    http://www.ncbi.nlm.nih.gov/pubmed/11297703?dopt=Citation
  51. Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M, Thoresen S, Youngman L, Hakulinen T. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries). Cancer Causes Control 2000; 11(9):783-790.
    http://www.ncbi.nlm.nih.gov/pubmed/11075866?dopt=Citation
  52. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000; 85(1):35-39.
    http://www.ncbi.nlm.nih.gov/pubmed/10585579?dopt=Citation
  53. Ward EM, Schulte P, Grajewski B, Andersen A, Patterson DG, Jr., Turner W, Jellum E, Deddens JA, Friedland J, Roeleveld N, Waters M, Butler MA, DiPietro E, Needham LL. Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomarkers Prev 2000; 9(12):1357-1367.
    http://www.ncbi.nlm.nih.gov/pubmed/11142422?dopt=Citation
  54. Akre O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A, Ekbom A. Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer 1999; 82(1):1-5.
    http://www.ncbi.nlm.nih.gov/pubmed/10360811?dopt=Citation
  55. Berg JP, Engeland A, Jellum E, Glattre E. Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case control study. Thyroid 1999; 9(3):285-288.
    http://www.ncbi.nlm.nih.gov/pubmed/10211606?dopt=Citation
  56. Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 1999; 34(4):353-360.
    http://www.ncbi.nlm.nih.gov/pubmed/10365894?dopt=Citation
  57. Luostarinen T, af G, V, Bjorge T, Eklund C, Hakama M, Hakulinen T, Jellum E, Koskela P, Paavonen J, Pukkala E, Schiller JT, Thoresen S, Youngman LD, Dillner J, Lehtinen M. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int J Cancer 1999; 80(6):818-822.
    http://www.ncbi.nlm.nih.gov/pubmed/10074912?dopt=Citation
  58. Bjorge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57(18):3989-3992.
    http://www.ncbi.nlm.nih.gov/pubmed/9307283?dopt=Citation
  59. Bjorge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315(7109):646-649.
    http://www.ncbi.nlm.nih.gov/pubmed/9310566?dopt=Citation
  60. Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 1997; 89(17):1293-1299.
    http://www.ncbi.nlm.nih.gov/pubmed/9293920?dopt=Citation
  61. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 1997; 71(4):545-551.
    http://www.ncbi.nlm.nih.gov/pubmed/9178806?dopt=Citation
  62. Jellum E, Dollekamp H, Brunsvig A, Gislefoss R. Diagnostic applications of chromatography and capillary electrophoresis. J Chromatogr B Biomed Sci Appl 1997; 689(1):155-164.
    http://www.ncbi.nlm.nih.gov/pubmed/9061490?dopt=Citation
  63. Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway. Cancer Epidemiol Biomarkers Prev 1997; 6(11):967-969.
    http://www.ncbi.nlm.nih.gov/pubmed/9367072?dopt=Citation
  64. Witherell HL, Hansen S, Jellum E, Orentreich N, Vogelman JH, Parsonnet J. Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection. J Infect Dis 1997; 176(6):1641-1644.
    http://www.ncbi.nlm.nih.gov/pubmed/9395383?dopt=Citation
  65. Jellum E, Dollekamp H, Blessum C. Capillary electrophoresis for clinical problem solving: analysis of urinary diagnostic metabolites and serum proteins. J Chromatogr B Biomed Appl 1996; 683(1):55-65.
    http://www.ncbi.nlm.nih.gov/pubmed/8876439?dopt=Citation
  66. Jellum E, Andersen A, Baklien K, Dalen A, Iversen OE, Lund-Larsen P, Theodorsen L, Orjasaeter H. The use of the Janus serum bank in studies related to the environment and cancer. Norwegian Acad Sci Letters 1996;23-32.
    www.ntnu.no/ojs/index.php/norepid/article/download/206/184
  67. Jellum E, Andersen A, Baklien K, Dalen A, Iversen OE, Lund-Larsen P, Theodorsen L, Orjasaeter H, Brunsvig A, Gislefoss R. Use of the Janus serum bank in cancer research. NORD Biotech 1996; 9:43-52.
  68. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. Experiences of the Janus Serum Bank in Norway. Environ Health Perspect 1995; 103 Suppl 3:85-88.
    http://www.ncbi.nlm.nih.gov/pubmed/7635118?dopt=Citation
  69. Berg JP, Glattre E, Haldorsen T, Hostmark AT, Bay IG, Johansen AF, Jellum E. Longchain serum fatty acids and risk of thyroid cancer: a population-based case-control study in Norway. Cancer Causes Control 1994; 5(5):433-439.
    http://www.ncbi.nlm.nih.gov/pubmed/7999965?dopt=Citation
  70. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330(18):1267-1271.
    http://www.ncbi.nlm.nih.gov/pubmed/8145781?dopt=Citation
  71. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. The JANUS serum bank. Sci Total Environ 1993; 139-140:527-535.
    http://www.ncbi.nlm.nih.gov/pubmed/8272856?dopt=Citation
  72. Paus E, Theodorsen L, Engeland A. Prostate-specific antigen in serum from blood donors with subsequent prostate cancer diagnosis. Eur J Cancer 1993; 29A(8):1221-1222.
    http://www.ncbi.nlm.nih.gov/pubmed/7686023?dopt=Citation
  73. Vatten LJ, Bjerve KS, Andersen A, Jellum E. Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case-control study from the Janus serum bank in Norway. Eur J Cancer 1993; 29A(4):532-538.
    http://www.ncbi.nlm.nih.gov/pubmed/8435206?dopt=Citation
  74. Chan CK, Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes Control 1991; 2(2):125-131.
    http://www.ncbi.nlm.nih.gov/pubmed/1651778?dopt=Citation
  75. Mueller N, Mohar A, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 1991; 49(3):387-393.
    http://www.ncbi.nlm.nih.gov/pubmed/1655660?dopt=Citation
  76. Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, Aaseth J. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 1989; 18(1):45-49.
    http://www.ncbi.nlm.nih.gov/pubmed/2722382?dopt=Citation
  77. Jellum E, Thorsrud AK. Profiling cells and body fluids--chromatography and two-dimensional electrophoresis as complementary techniques. J Chromatogr 1989; 488(1):105-127.
    http://www.ncbi.nlm.nih.gov/pubmed/2715280?dopt=Citation
  78. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 320(11):689-695.
    http://www.ncbi.nlm.nih.gov/pubmed/2537928?dopt=Citation
  79. Thoresen SO, Myking O, Glattre E, Rootwelt K, Andersen A, Foss OP. Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer. Br J Cancer 1988; 57(1):105-108.
    http://www.ncbi.nlm.nih.gov/pubmed/3348941?dopt=Citation
  80. Zurawski VR, Jr., Orjaseter H, Andersen A, Jellum E. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer 1988; 42(5):677-680.
    http://www.ncbi.nlm.nih.gov/pubmed/3182103?dopt=Citation
  81. Jellum E, Andersen A, Orjasaeter H, Foss OP, Theodorsen L, Lund-Larsen P. The JANUS serum bank and early detection of cancer. Biochim Clinica 1987; 11:191-195.
  82. Kotlar HK, Sanner T, Eker P, Pihl A, Orjasaeter H, Harvei S, Theodorsen L, Jellum E. Immune anti-tumor response in the preclinical period of lung cancer. Eur J Cancer Clin Oncol 1982; 18(3):317-319.
    http://www.ncbi.nlm.nih.gov/pubmed/7201399?dopt=Citation
  83. Orjasaeter H. The "Janus" serum research programme: a multipurpose project for retrospective as well as prospective investigations of cancer. Acta Pathol Microbiol Scand Suppl 1974; Suppl 248:175-179.
    http://www.ncbi.nlm.nih.gov/pubmed/4451120?dopt=Citation

Siden ble sist redigert 02.10.2011 13:01:28 av IJRE